Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
FDA to Hold Public Hearing on Medication Guide Program
The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13 to gain feedback on the agency's Medication Guide program. (Medication Guides are handouts given to patients by pharmacists each time certain prescription drugs and biological products are dispensed. They contain FDA-approved patient information aimed at preventing serious adverse events.) Under current rules (21 CFR part 208), Medication Guides are required only if the drug has certain characteristics, such as a propensity to cause serious adverse health problems due to side effects or improper use. Currently, approximately 240 medications come with Medication Guides. The feedback received at the hearing will be used to assess the effectiveness of the guides and to discover and deal with their distribution challenges. For more information, please see: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01606.html.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
A federal district court in Miami, FL, has ruled that former National Basketball Association star Shaquille O'Neal will have to face a lawsuit over his promotion of unregistered securities in the form of cryptocurrency tokens and that he was a "seller" of these unregistered securities.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
Blockchain domain names offer decentralized alternatives to traditional DNS-based domain names, promising enhanced security, privacy and censorship resistance. However, these benefits come with significant challenges, particularly for brand owners seeking to protect their trademarks in these new digital spaces.
This article reviews the fundamental underpinnings of the concept of insurable interest, and certain recent cases that have grappled with the scope of insurable interest and have articulated a more meaningful application of the concept to claims under first-party property policies.